Search

Avian malaria has played a significant role in causing extinctions, population declines, and limiting the elevational distribution of Hawaiian honeycreepers. Most threatened and endangered honeycreepers only exist in high-elevation forests where the risk of malaria infection is limited. Because Culex mosquito vectors and avian malaria dynamics are strongly influenced by temperature and rainfall, future climate change is predicted to expand malaria infection to high-elevation forests and intensify malaria infection at lower elevations, likely resulting in future extinctions and loss of avian biodiversity in Hawaii. Novel, landscape-level mosquito control strategies are promising, but are logistically challenging and require costly long-term efforts. As an alternative or supplemental strategy, we evaluated the potential of releasing a gene-edited malaria-resistant honeycreeper (Iiwi, Drepanis coccinea) in Hawaiian rainforests; a strategy known as facilitated adaptation. While this approach also has significant technical challenges and costs, it may offer a more permanent solution to increasing malaria threats. If malaria-resistant honeycreepers can be developed, facilitated adaptation may provide a practical strategy for the reestablishment of abundant avian populations in Hawaiian forests. A successful strategy could be the release of malaria-resistant Iiwi in mid-elevation forests where development of a resistant population has the best chance of success. Establishment of a resistant Iiwi population could provide a source for dispersal and development of resistant populations in high-elevation forests and a permanent source of resistant individuals for translocation to other vulnerable areas.

To investigate the immune response to exoerythrocytic stages of malaria parasites, a rhesus monkey was immunized with autologous primary hepatocyte cultures infected with 7-day-old liver stage parasites of Plasmodium cynomolgi. A primary antibody response against EE stage antigens was obtained, and boosted after injection of homologous viable sporozoites. Antibodies directed against sporozoites and blood stages were also detected. The polyvalent immune response observed demonstrates the antigenicity of the liver stages and suggests their involvement in the general immune response against malaria.

Three novel non-CS antigens have been identified on P. falciparum and P. berghei sporozoites and exoerythrocytic parasites. CSP-2 is a sporozoite surface protein common to P. falciparum and P. berghei that elicits antibody-mediated protection, and is also found within P. berghei EE parasites. LSA is a P. falciparum EE-specific antigen localized within the parasitophorous vacuole. LSA-2 is a P. berghei EE-specific antigen, localized on the parasitophorous vacuole membrane, that protected mice to P. berghei sporozoite challenge, and elicited cytotoxic T cells that killed P. berghei EE parasites in vitro.

During the past ten years, new and remarkable information about the genetic diversity and phylogenetic relationships of parasites has been obtained through use of sensitive polymerase chain reaction-based techniques [1–8]. DNA sequences of numerous species have been deposited in GenBank, an invaluable resource for the study of parasites and other organisms. However, the majority of DNA sequences in GenBank, especially those obtained from wildlife parasites, have been identified only to the level of genus, and sometimes at even higher levels of classification.

In several recent publications [1–4], the term ‘malaria parasites’ has been used loosely to include all pigmented (and even some non-pigmented) haemosporidian parasites (Sporozoa: Haemosporida) that inhabit red blood cells and sometimes white blood cells. This terminology was in common use during the first half of the 20th century when there was considerable debate about the host range and identity of many of these parasites, but was eventually abandoned because it obscured basic biological differences among these organisms.